Viking Therapeutics Inc logo

Viking Therapeutics Inc

VKTX
Healthcare|Biotechnology|USA
$38.86
-2.28 (-5.54%)
Tangible Book
$4.33

Upcoming Data Readouts (2)

Jul 2027
Est. completion
P3Weight Loss
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
NCT07104383n=1,100
Jul 2027
Est. completion
P3Weight Loss
VK2735 for Weight Management Phase 3
NCT07104500n=4,500

Recent Press Releases